Water → HCID 21081842, compound
Reaction equation
[N:1]1([C:8]2[CH:9]=[CH:10][C:11]3[N:12]([C:14]([CH2:17]P(=O)(OCC)OCC)=[N:15][N:16]=3)[N:13]=2)[CH2:7][CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.CC(C)([O-])C.[K+].[Br:32][C:33]1[CH:40]=[CH:39][CH:38]=[CH:37][C:34]=1[CH:35]=O.O>C1COCC1>[N:1]1([C:8]2[CH:9]=[CH:10][C:11]3[N:12]([C:14](/[CH:17]=[CH:35]/[C:34]4[CH:37]=[CH:38][CH:39]=[CH:40][C:33]=4[Br:32])=[N:15][N:16]=3)[N:13]=2)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7]1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of diethyl [(6-azepan-1-yl-1,2,4-triazolo[4,3-b]pyridazin-3-yl)methyl]phosphonate (367 mg) in THF (10 ml), potassium tert-butoxide (127 mg) was added with cooling in an ice bath, and the mixture was stirred at room temperature for 40 minutes. The resultant red solution was combined with 2-bromobenzaldehyde (0.128 ml), and stirred at room temperature for further 1 hour. The reaction solution was combined with water, and extracted with ethyl acetate. The extract was washed with water and brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The resultant white solids were recrystallized from methanol to obtain 6-azepan-1-yl-3-[(E)-2-(2-bromophenyl)vinyl]-1,2,4-triazolo[4,3-b]pyridazine (152 mg) as colorless crystals.
Workup
- temperaturewith cooling in an ice bath
- stirringstirred at room temperature for further 1 hour
- extractionextracted with ethyl acetate
- washThe extract was washed with water and brine
- dry with materialdried over anhydrous magnesium sulfate
- concentrationconcentrated under reduced pressure
- customThe resultant white solids were recrystallized from methanol
Sources & evidence
- ORD record
- ord-7de38185b83c4d93bd079106bb070ae6
- Source dataset
- uspto-grants-2007_02
- Patent number
- US07173033B2
Reaction notes
Loading…